1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits for the stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
2.3. Data Validation
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Supplier
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. COMPUTER-AIDED DRUG DISCOVERY MARKET BY TYPE
5.1. Introduction
5.2. Structure-Based Drug Design
5.3. Ligand-Based Drug Design
5.4. Sequence-Based Approaches
6. COMPUTER-AIDED DRUG DISCOVERY MARKET BY THERAPEUTIC AREA
6.1. Introduction
6.2. Oncology
6.3. Neurology
6.4. Cardiovascular Disease
6.5. Respiratory Disease
6.6. Others
7. COMPUTER-AIDED DRUG DISCOVERY MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical Companies
7.3. Biotechnology Companies
7.4. Research Laboratories
8. COMPUTER-AIDED DRUG DISCOVERY MARKET BY GEOGRAPHY
8.1. Global Overview
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Rest of South America
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Rest of Europe
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. United Arab Emirates
8.5.3. Rest of the Middle East and Africa
8.6. Asia-Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Rest of Asia-Pacific
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Aragen Life Sciences Pvt. Ltd.
10.2. Bioduro-Sundia
10.3. BOC Sciences
10.4. Aris Pharmaceuticals, Inc.
10.5. AstraZeneca
10.6. Schrödinger, Inc.
10.7. Bayer AG
10.8. Charles River Laboratories
10.9. Albany Molecular Research Inc. (Curia Global, Inc.)
10.10. Insilico Medicine